Dividend
-
-
-
-
-
-
-
QIAGEN partners with NVIDIA to integrate AI into drug discovery platform
-
-
-
-
-
-
-
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
-
-
-
-
-
-
-
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026
-
-
-
-
-
-
-
Qiagen (QGEN) Appoints Stephen Rusckowski as Board Chair
-
-
-
-
-
-
-
Quarterly Changes to the NASDAQ Q-50 Index
-
-
-
445,814 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

